Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 4/20 | 0.40 |
| ▸ | SGPL1 | O95470 | 1/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.39 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.38 |
| ▸ | CXCR3 | P49682 | 3/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.36 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.36 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.36 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.36 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12961937 | 0.91 | KDM4E (0.40) | SCDSGPL1KDM4EABL1LMNA | |
| SCHEMBL385660 | 0.88 | SGPL1 (0.39) | SCDSGPL1HCRTR1HCRTR2KDM4E | |
| SCHEMBL12961901 | 0.85 | IKBKE (0.45) | SCDSGPL1KDM4EABL1LMNA | |
| SCHEMBL12962019 | 0.84 | LIPG (0.50) | SGPL1KDM4EABL1LMNACNR1 | |
| SCHEMBL13951318 | 0.84 | CNR2 (0.38) | SCDSGPL1KDM4EABL1LMNA | |
| SCHEMBL16433606 | 0.82 | CXCR3 (0.38) | SGPL1HCRTR1HCRTR2KDM4EABL1 | |
| SCHEMBL12961963 | 0.82 | CXCR3 (0.38) | SCDSGPL1KDM4EABL1LMNA | |
| SCHEMBL385891 | 0.80 | HCRTR1 (0.41) | SCDHCRTR1HCRTR2KDM4EABL1 | |
| SCHEMBL10107103 | 0.80 | HCRTR1 (0.41) | SCDHCRTR1HCRTR2KDM4EABL1 | |
| SCHEMBL12961962 | 0.80 | CXCR3 (0.38) | SCDKDM4EABL1LMNACNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101768-B2 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-7868178-B2 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2011-01-11 | — | — | US | disclosed |
| US-20090143443-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2009-06-04 | — | — | US | disclosed |
| US-7485727-B2 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2009-02-03 | — | — | US | disclosed |
| US-20080319003-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080045569-A1 | Cyclic Amine Compound and Pest Control Agent | NIPPON SODA CO., LTD. (JP) | 2008-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045569-A1 | Cyclic Amine Compound and Pest Control Agent | H1-0, H1-2, H1-4 | SCD 4747/4885SGPL1 2351/4885HCRTR1 41/4885 |
| US-20090143443-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | TAAR1, CBR3, CBR1 | SCD 3537/4885SGPL1 1760/4885HCRTR1 13/4885 |
| US-20080319003-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | H1-0, H1-2, H1-4 | SCD 4725/4885SGPL1 2416/4885HCRTR1 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.